We serve Chemical Name:2-Methyl-2-propanyl 7-nitro-3,4-dihydro-2(1H)-isoquinolinecarboxy late CAS:171049-42-6 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:2-Methyl-2-propanyl 7-nitro-3,4-dihydro-2(1H)-isoquinolinecarboxy late
CAS.NO:171049-42-6
Synonyms:N-tert-butoxycarbonyl-7-nitro-1,2,3,4-tetra hydroisoquinoline
Molecular Formula:C14H18N2O4
Molecular Weight:278.30400
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:N/A
Density:N/A
Index of Refraction:
PSA:75.36000
Exact Mass:278.12700
LogP:3.34910
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like N-tert-butoxycarbonyl-7-nitro-1,2,3,4-tetra hydroisoquinoline chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,N-tert-butoxycarbonyl-7-nitro-1,2,3,4-tetra hydroisoquinoline physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,N-tert-butoxycarbonyl-7-nitro-1,2,3,4-tetra hydroisoquinoline Use and application,N-tert-butoxycarbonyl-7-nitro-1,2,3,4-tetra hydroisoquinoline technical grade,usp/ep/jp grade.
Related News: The outlay will be used to grow Takeda’s portfolio of treatments and boost capacity to manufacture additional products for the rare disease community, Stephen Hatke, Takeda’s Thousand Oaks site head, said in a YouTube video about the expansion. The company didn’t name the specific products it plans to make there. (4-methyl-2-oxopentyl) N-pyridin-2-ylcarbamodithioate manufacturers The factory is part of a partnership with Nichepharm Lifesciences of India. Recipharm has an 8% stake in that company after an investment two years ago. Benzoic acid, 2-bromo-, 2-[[(3b)-cholest-5-en-3-yl]oxy]ethyl ester suppliers “The Agency also noted that no effect was seen in the two studies that included patients from EU populations, including the most recent study which involved patients who were receiving the maximum and optimal treatment for their Parkinson’s disease,” EMA said. 1-(2-tetrahydrofuryl)-3-(1-phenyl)-propyn-2-ol vendor & factory.
